Cubist recalls four Cubicin lots

Cubist Pharmaceuticals (CBST) voluntarily recalls four lots of Cubicin "due to the presence of particulate matter found in a number of vials from these lots."

No adverse events have been reported. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs